APA (7th ed.) Citation

JY, D., M, G., X, F., HH, Y., WC, L., MY, Y., . . . Q, Z. (2025). Clinical and dynamic circulating cytokines profile features of long-term progression-free survival benefit to immune checkpoint inhibitors in advanced non-small cell lung cancer. Cancer immunology, immunotherapy : CII, 74(6), 173. https://doi.org/10.1007/s00262-025-03984-7

Chicago Style (17th ed.) Citation

JY, Deng, et al. "Clinical and Dynamic Circulating Cytokines Profile Features of Long-term Progression-free Survival Benefit to Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer." Cancer Immunology, Immunotherapy : CII 74, no. 6 (2025): 173. https://doi.org/10.1007/s00262-025-03984-7.

MLA (9th ed.) Citation

JY, Deng, et al. "Clinical and Dynamic Circulating Cytokines Profile Features of Long-term Progression-free Survival Benefit to Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer." Cancer Immunology, Immunotherapy : CII, vol. 74, no. 6, 2025, p. 173, https://doi.org/10.1007/s00262-025-03984-7.